MA41158A - Composition pharmaceutique comprenant un composé d'amide hétérocyclique aromatique contenat de l'azote bicyclique en tant que principe actif - Google Patents

Composition pharmaceutique comprenant un composé d'amide hétérocyclique aromatique contenat de l'azote bicyclique en tant que principe actif

Info

Publication number
MA41158A
MA41158A MA041158A MA41158A MA41158A MA 41158 A MA41158 A MA 41158A MA 041158 A MA041158 A MA 041158A MA 41158 A MA41158 A MA 41158A MA 41158 A MA41158 A MA 41158A
Authority
MA
Morocco
Prior art keywords
pharmaceutical composition
active ingredient
compound containing
aromatic heterocyclic
composition consisting
Prior art date
Application number
MA041158A
Other languages
English (en)
Inventor
Takeyuki Nagashima
Susumu Tsujimoto
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of MA41158A publication Critical patent/MA41158A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA041158A 2014-12-09 2015-12-07 Composition pharmaceutique comprenant un composé d'amide hétérocyclique aromatique contenat de l'azote bicyclique en tant que principe actif MA41158A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014249350 2014-12-09

Publications (1)

Publication Number Publication Date
MA41158A true MA41158A (fr) 2017-10-17

Family

ID=56107386

Family Applications (1)

Application Number Title Priority Date Filing Date
MA041158A MA41158A (fr) 2014-12-09 2015-12-07 Composition pharmaceutique comprenant un composé d'amide hétérocyclique aromatique contenat de l'azote bicyclique en tant que principe actif

Country Status (15)

Country Link
US (1) US20170360780A1 (fr)
EP (1) EP3231425A1 (fr)
JP (1) JPWO2016093203A1 (fr)
KR (1) KR20170088882A (fr)
CN (1) CN106999488A (fr)
AU (1) AU2015362516A1 (fr)
BR (1) BR112017012379A2 (fr)
CA (1) CA2970232A1 (fr)
IL (1) IL252663A0 (fr)
MA (1) MA41158A (fr)
MX (1) MX2017007643A (fr)
RU (1) RU2017120173A (fr)
SG (1) SG11201704593QA (fr)
TW (1) TW201636021A (fr)
WO (1) WO2016093203A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117045800A (zh) * 2022-05-06 2023-11-14 上海科技大学 mTOR抑制剂增强靶向蛋白降解药物功效的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7410998B2 (en) * 2000-09-06 2008-08-12 The Scripps Research Institute Inhibitors of NADH:ubiquinone oxidoreductase
HK1220446A1 (en) * 2013-06-10 2017-05-05 Astellas Pharma Inc. Bicyclic nitrogen-containing aromatic heterocyclic amide compound

Also Published As

Publication number Publication date
AU2015362516A1 (en) 2017-06-29
MX2017007643A (es) 2017-10-11
JPWO2016093203A1 (ja) 2017-09-14
EP3231425A1 (fr) 2017-10-18
TW201636021A (zh) 2016-10-16
BR112017012379A2 (pt) 2018-04-24
RU2017120173A (ru) 2019-01-11
CA2970232A1 (fr) 2016-06-16
IL252663A0 (en) 2017-08-31
KR20170088882A (ko) 2017-08-02
WO2016093203A1 (fr) 2016-06-16
CN106999488A (zh) 2017-08-01
US20170360780A1 (en) 2017-12-21
SG11201704593QA (en) 2017-07-28

Similar Documents

Publication Publication Date Title
MX2018003432A (es) Compuestos heterociclicos y usos de los mismos.
PH12017500276A1 (en) Aminopyrimidinyl compounds as jak inhibitors
CL2016002072A1 (es) 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 para el tratamiento de la enfermedad de alzheimer
TW201613911A (en) Heterocyclic compounds and uses thereof
DOP2019000193A (es) Nuevo compuesto heterocíclico, su método de preparación y composición farmacéutica que lo comprende
EA202090688A1 (ru) Бис-амидные соединения, активирующие саркомер, и варианты их применения
CR20130487A (es) 1,3-oxazinas como inhibidores de BACE1 y/o BACE2
NI201700029A (es) Compuestos y composiciones como inhibidores de quinasa raf.
MX2018004008A (es) Inhibidores de isoindolinona de la interaccion mdm2-p53 que tienen actividad antineoplasica.
MX2018003993A (es) Inhibidores de isoindolinona de la interaccion mdm2-p53 que tienen actividad antineoplasica.
ME03775B (fr) Composition médicinale comprenant un composé de carboxamide hétérocyclique diamino en tant qu'agent actif
EP3480186A4 (fr) Nouveau dérivé d'aryléthane et composition pharmaceutique contenant ce dérivé comme principe actif
MX388175B (es) Compuestos terapéuticos y métodos para utilizarlos
MX2016014939A (es) Derivados de carboxamida.
EA201890534A1 (ru) Новые аннелированные феноксиацетамиды
EP3360551A4 (fr) Composition pharmaceutique contenant un composé d'arylalkylamine
EP2871187A4 (fr) Nouveau composé ou sel pharmaceutiquement acceptable de celui-ci, et composition pharmaceutique le contenant à titre de principe actif
MX383069B (es) Farmaceutico que contiene inhibidor de transportador de fosfato dependiente de sodio.
EA201990313A1 (ru) Производное триазолопиразинона, пригодное в качестве ингибитора фдэ1 человека
EP3372231A4 (fr) Composition pharmaceutique pour l'immunothérapie anticancéreuse et/ou pour l'immunostimulation, contenant comme principe actif un composé diamino carboxamide hétérocyclique
CL2017002229A1 (es) Inhibidores de bace1.
EP3459936A4 (fr) Nouveau dérivé d'aryléthane et composition pharmaceutique contenant ce dérivé comme principe actif
EP3327004A4 (fr) Composé hétérocyclique contenant de l'azote
MA41158A (fr) Composition pharmaceutique comprenant un composé d'amide hétérocyclique aromatique contenat de l'azote bicyclique en tant que principe actif
EP3572407A4 (fr) Dérivé d'isoxazolin-5-one et herbicide le contenant en tant que principe actif